These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20133255)

  • 41. Inflammatory breast cancer: what progress have we made?
    Dawood S; Cristofanilli M
    Oncology (Williston Park); 2011 Mar; 25(3):264-70, 273. PubMed ID: 21548470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic determinants of aggressive breast cancer.
    Ventura AC; Merajver SD
    Annu Rev Med; 2008; 59():199-212. PubMed ID: 17914925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular targets for treatment of inflammatory breast cancer.
    Yamauchi H; Cristofanilli M; Nakamura S; Hortobagyi GN; Ueno NT
    Nat Rev Clin Oncol; 2009 Jul; 6(7):387-94. PubMed ID: 19468291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression.
    Colpaert CG; Vermeulen PB; Benoy I; Soubry A; van Roy F; van Beest P; Goovaerts G; Dirix LY; van Dam P; Fox SB; Harris AL; van Marck EA
    Br J Cancer; 2003 Mar; 88(5):718-25. PubMed ID: 12618881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. What is the best systemic treatment for newly diagnosed inflammatory breast cancer?-a narrative review.
    Chainitikun S; Mingmalairak S; Parinyanitikul N
    Chin Clin Oncol; 2021 Dec; 10(6):55. PubMed ID: 34670376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Update on the management of inflammatory breast cancer.
    Cristofanilli M; Buzdar AU; Hortobágyi GN
    Oncologist; 2003; 8(2):141-8. PubMed ID: 12697939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Case of a Bilateral Inflammatory Breast Cancer: A Case Report.
    Kurtz J; Halaharvi D; Sarwar S; Cripe M
    Breast J; 2016 May; 22(3):342-346. PubMed ID: 26899495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Racial and Socioeconomic Disparities Are More Pronounced in Inflammatory Breast Cancer Than Other Breast Cancers.
    Denu RA; Hampton JM; Currey A; Anderson RT; Cress RD; Fleming ST; Lipscomb J; Wu XC; Wilson JF; Trentham-Dietz A
    J Cancer Epidemiol; 2017; 2017():7574946. PubMed ID: 28894467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line.
    Hoffmeyer MR; Wall KM; Dharmawardhane SF
    Cancer Cell Int; 2005 Apr; 5(1):11. PubMed ID: 15857504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting Signaling Pathways in Inflammatory Breast Cancer.
    Wang X; Semba T; Phi LTH; Chainitikun S; Iwase T; Lim B; Ueno NT
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32883032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Farnesyltransferase inhibitors: potential therapeutic for inflammatory breast cancer?
    Prendergast GC
    Breast Dis; 2002; 15():25-32. PubMed ID: 15687643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toward precision medicine in inflammatory breast cancer.
    Viale G; Marra A; Curigliano G; Criscitiello C
    Transl Cancer Res; 2019 Oct; 8(Suppl 5):S469-S478. PubMed ID: 35117125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease.
    Suárez-Arroyo IJ; Feliz-Mosquea YR; Pérez-Laspiur J; Arju R; Giashuddin S; Maldonado-Martínez G; Cubano LA; Schneider RJ; Martínez-Montemayor MM
    Am J Cancer Res; 2016; 6(8):1720-40. PubMed ID: 27648361
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The patient advocate view.
    Johnson GO; Kirschenbaum M; Mason G; Rush LR
    Breast Dis; 2005-2006; 22():3-8. PubMed ID: 16735782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does secondary inflammatory breast cancer represent post-surgical metastatic disease?
    Hashmi S; Zolfaghari L; Levine PH
    Cancers (Basel); 2012 Feb; 4(1):156-64. PubMed ID: 24213233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10
    Woodward WA; Cristofanilli M; Merajver SD; Van Laere S; Pusztai L; Bertucci F; Berditchevski F; Polyak K; Overmoyer B; Devi GR; Sterneck E; Schneider R; Debeb BG; Wang X; van Golen KL; El-Zein R; Rahal OM; Alexander A; Reuben JM; Krishnamurthy S; Lucci A; Ueno NT
    J Cancer; 2017; 8(17):3607-3614. PubMed ID: 29667990
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inflammatory breast cancer clusters: A hypothesis.
    Levine PH; Hashmi S; Minaei AA; Veneroso C
    World J Clin Oncol; 2014 Aug; 5(3):539-45. PubMed ID: 25114867
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Innovation in biosafety oversight: The Harvard Catalyst Common Reciprocal IBC Reliance Authorization Agreement.
    Caruso R; Myatt T; Bierer BE
    J Clin Transl Sci; 2020 Apr; 4(2):90-95. PubMed ID: 32313697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated expression of wildtype RhoC promotes ErbB2- and Pik3ca-induced mammary tumor formation.
    Raghuram N; Temel EI; Kawamata T; Kozma KJ; Loch AJ; Wang W; Adams JR; Muller WJ; Egan SE
    Breast Cancer Res; 2024 May; 26(1):86. PubMed ID: 38807216
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007-2009.
    Hirko KA; Soliman AS; Banerjee M; Ruterbusch J; Harford JB; Merajver SD; Schwartz K
    Breast J; 2014; 20(2):185-91. PubMed ID: 24372839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.